Gut Microbiota: Its Role in Liver Disease and Atherosclerosis
A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Gut Microbiota".
Deadline for manuscript submissions: closed (20 April 2022) | Viewed by 4724
Special Issue Editor
Interests: cardiology; internal medicine; heart failure; atherosclerosis; arterial hypertension
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The rising interest in gut microbiota in the last decade is due to increased knowledge in this area and also to technological advancements. The human gastrointestinal tract represents the host of more than 2000 different species of bacteria, archaea and eukaryotic microbes that co-evolved with the host over thousands of years, contributing to metabolic functions, protecting against pathogens, educating the immune system, and, through these basic functions, directly or indirectly affecting most of the physiologic functions. The aim and scope of the Special Issue is to present the latest knowledge on gut microbiota influence on liver disease and atherosclerosis. We also will try to focus on microbiota as a therapeutic target in the prevention of cardiovascular diseases and the beneficial mechanisms of probiotic administration related to cardiovascular risks.
Prof. Dr. Daniel Florin Lighezan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gut microbiota
- microbiome
- liver disease
- atherosclerosis
- cardiovascular disease
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
